DAVITA INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
DAVITA INC. (DVA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 1.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-11
- DAVITA INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was 1.20%, a 200.00% increase from fiscal 2024.
- DAVITA INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was 0.40%, a 50.00% decline from fiscal 2023.
- DAVITA INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 0.80%.
- DAVITA INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -1.60%, a 166.67% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.20% 10-K · filed 2026-02-11 | |
| 2024-12-31 | 0.40% 10-K · filed 2026-02-11 | -1.10% 10-K · filed 2025-02-13 |
| 2023-12-31 | 0.80% 10-K · filed 2026-02-11 | 1.10% 10-K · filed 2024-02-14 |
| 2022-12-31 | -1.60% 10-K · filed 2025-02-13 | 1.60% 10-K · filed 2023-02-22 |
| 2021-12-31 | 2.40% 10-K · filed 2024-02-14 | -2.40% 10-K · filed 2022-02-11 |
| 2020-12-31 | 0.00% 10-K · filed 2023-02-22 | |
| 2019-12-31 | 0.50% 10-K · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |